MY110249A
(en)
*
|
1989-05-31 |
1998-03-31 |
Univ Florida State |
Method for preparation of taxol using beta lactam
|
US5698582A
(en)
*
|
1991-07-08 |
1997-12-16 |
Rhone-Poulenc Rorer S.A. |
Compositions containing taxane derivatives
|
US6005138A
(en)
|
1991-09-23 |
1999-12-21 |
Florida State University |
Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
|
US6018073A
(en)
*
|
1991-09-23 |
2000-01-25 |
Florida State University |
Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
|
US5728850A
(en)
*
|
1991-09-23 |
1998-03-17 |
Florida State University |
Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
|
US6521660B2
(en)
|
1991-09-23 |
2003-02-18 |
Florida State University |
3′-alkyl substituted taxanes and pharmaceutical compositions containing them
|
US6335362B1
(en)
*
|
1991-09-23 |
2002-01-01 |
Florida State University |
Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
|
US5284864A
(en)
|
1991-09-23 |
1994-02-08 |
Florida State University |
Butenyl substituted taxanes and pharmaceutical compositions containing them
|
US5998656A
(en)
|
1991-09-23 |
1999-12-07 |
Florida State University |
C10 tricyclic taxanes
|
US5710287A
(en)
*
|
1991-09-23 |
1998-01-20 |
Florida State University |
Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
|
US5654447A
(en)
*
|
1991-09-23 |
1997-08-05 |
Florida State University |
Process for the preparation of 10-desacetoxybaccatin III
|
US6794523B2
(en)
|
1991-09-23 |
2004-09-21 |
Florida State University |
Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
|
US5721268A
(en)
*
|
1991-09-23 |
1998-02-24 |
Florida State University |
C7 taxane derivatives and pharmaceutical compositions containing them
|
US5714513A
(en)
*
|
1991-09-23 |
1998-02-03 |
Florida State University |
C10 taxane derivatives and pharmaceutical compositions
|
EP1001036B1
(de)
*
|
1992-01-15 |
2004-10-20 |
E.R. Squibb & Sons, Inc. |
Enzymatische Verfahren zur Aüftrennüng von Enantiomeren-Mischungen nützlich als Zwischenprodukte zur Herstellung von Taxanen
|
JPH069600A
(ja)
*
|
1992-05-06 |
1994-01-18 |
Bristol Myers Squibb Co |
タクソールのベンゾエート誘導体
|
US5614549A
(en)
*
|
1992-08-21 |
1997-03-25 |
Enzon, Inc. |
High molecular weight polymer-based prodrugs
|
CA2109861C
(en)
*
|
1992-12-04 |
1999-03-16 |
Shu-Hui Chen |
6,7-modified paclitaxels
|
US5380751A
(en)
*
|
1992-12-04 |
1995-01-10 |
Bristol-Myers Squibb Company |
6,7-modified paclitaxels
|
US5973160A
(en)
*
|
1992-12-23 |
1999-10-26 |
Poss; Michael A. |
Methods for the preparation of novel sidechain-bearing taxanes
|
DE69333905T2
(de)
|
1992-12-23 |
2006-08-03 |
Bristol-Myers Squibb Co. |
Seitenkette tragende Taxane und deren Zwischenprodukte
|
MX9308012A
(es)
*
|
1992-12-24 |
1994-08-31 |
Bristol Myers Squibb Co |
Eteres fosfonooximetilicos de derivados de taxano, solubles en agua y composiciones farmaceuticas que los incluyen.
|
US5646176A
(en)
*
|
1992-12-24 |
1997-07-08 |
Bristol-Myers Squibb Company |
Phosphonooxymethyl ethers of taxane derivatives
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
TW467896B
(en)
*
|
1993-03-19 |
2001-12-11 |
Bristol Myers Squibb Co |
Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
|
TW397866B
(en)
*
|
1993-07-14 |
2000-07-11 |
Bristol Myers Squibb Co |
Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
|
CA2129288C
(en)
*
|
1993-08-17 |
2000-05-16 |
Jerzy Golik |
Phosphonooxymethyl esters of taxane derivatives
|
FR2711370B1
(fr)
*
|
1993-10-18 |
1996-01-05 |
Rhone Poulenc Rorer Sa |
Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
CA2174350A1
(en)
*
|
1993-10-20 |
1995-04-27 |
Richard B. Greenwald |
2'- and/or 7- substituted taxoids
|
FR2712289B1
(fr)
*
|
1993-11-08 |
1996-01-05 |
Rhone Poulenc Rorer Sa |
Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
IL127599A
(en)
*
|
1994-01-28 |
2004-06-01 |
Upjohn Co |
Process for preparing isotaxol analogs
|
GB9405400D0
(en)
*
|
1994-03-18 |
1994-05-04 |
Erba Carlo Spa |
Taxane derivatives
|
US5677470A
(en)
|
1994-06-28 |
1997-10-14 |
Tanabe Seiyaku Co., Ltd. |
Baccatin derivatives and processes for preparing the same
|
US6201140B1
(en)
|
1994-07-28 |
2001-03-13 |
Bristol-Myers Squibb Company |
7-0-ethers of taxane derivatives
|
JPH10508022A
(ja)
*
|
1994-10-28 |
1998-08-04 |
ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク |
タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用
|
US6458976B1
(en)
|
1994-10-28 |
2002-10-01 |
The Research Foundation Of State University Of New York |
Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
|
US6500858B2
(en)
|
1994-10-28 |
2002-12-31 |
The Research Foundation Of The State University Of New York |
Taxoid anti-tumor agents and pharmaceutical compositions thereof
|
CA2162759A1
(en)
*
|
1994-11-17 |
1996-05-18 |
Kenji Tsujihara |
Baccatin derivatives and processes for preparing the same
|
US5489589A
(en)
*
|
1994-12-07 |
1996-02-06 |
Bristol-Myers Squibb Company |
Amino acid derivatives of paclitaxel
|
US5580899A
(en)
*
|
1995-01-09 |
1996-12-03 |
The Liposome Company, Inc. |
Hydrophobic taxane derivatives
|
US5840929A
(en)
*
|
1995-04-14 |
1998-11-24 |
Bristol-Myers Squibb Company |
C4 methoxy ether derivatives of paclitaxel
|
US5801191A
(en)
*
|
1995-06-01 |
1998-09-01 |
Biophysica Foundation |
Taxoids
|
AU716005B2
(en)
|
1995-06-07 |
2000-02-17 |
Cook Medical Technologies Llc |
Implantable medical device
|
US5807888A
(en)
*
|
1995-12-13 |
1998-09-15 |
Xechem International, Inc. |
Preparation of brominated paclitaxel analogues and their use as effective antitumor agents
|
US5854278A
(en)
*
|
1995-12-13 |
1998-12-29 |
Xechem International, Inc. |
Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
|
US5654448A
(en)
*
|
1995-10-02 |
1997-08-05 |
Xechem International, Inc. |
Isolation and purification of paclitaxel from organic matter containing paclitaxel, cephalomannine and other related taxanes
|
US6177456B1
(en)
|
1995-10-02 |
2001-01-23 |
Xechem International, Inc. |
Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor
|
US5840748A
(en)
*
|
1995-10-02 |
1998-11-24 |
Xechem International, Inc. |
Dihalocephalomannine and methods of use therefor
|
EP0932399B1
(de)
|
1996-03-12 |
2006-01-04 |
PG-TXL Company, L.P. |
Wasserlösliche paclitaxel-prodrogen
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
EP0927175A4
(de)
*
|
1996-05-06 |
2002-05-22 |
Univ Florida State |
1-deoxybaccatin iii, 1-deoxytaxol und 1-deoxytaxol-analoge und verfahren zu ihrer herstellung
|
US5635531A
(en)
*
|
1996-07-08 |
1997-06-03 |
Bristol-Myers Squibb Company |
3'-aminocarbonyloxy paclitaxels
|
US5773464A
(en)
*
|
1996-09-30 |
1998-06-30 |
Bristol-Myers Squibb Company |
C-10 epoxy taxanes
|
US8137684B2
(en)
*
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US5977386A
(en)
*
|
1996-12-24 |
1999-11-02 |
Bristol-Myers Squibb Company |
6-thio-substituted paclitaxels
|
US5902822A
(en)
*
|
1997-02-28 |
1999-05-11 |
Bristol-Myers Squibb Company |
7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
|
US5912264A
(en)
*
|
1997-03-03 |
1999-06-15 |
Bristol-Myers Squibb Company |
6-halo-or nitrate-substituted paclitaxels
|
US6103698A
(en)
*
|
1997-03-13 |
2000-08-15 |
Basf Aktiengesellschaft |
Dolastatin-15 derivatives in combination with taxanes
|
GB9705903D0
(en)
|
1997-03-21 |
1997-05-07 |
Elliott Gillian D |
VP22 Proteins and uses thereof
|
US6017935A
(en)
*
|
1997-04-24 |
2000-01-25 |
Bristol-Myers Squibb Company |
7-sulfur substituted paclitaxels
|
WO2002085337A1
(en)
|
2001-04-20 |
2002-10-31 |
The University Of British Columbia |
Micellar drug delivery systems for hydrophobic drugs
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
JP2003521514A
(ja)
|
2000-02-02 |
2003-07-15 |
フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド |
抗腫瘍剤としてのc10ヘテロ置換アセテートタキサン
|
CO5280224A1
(es)
|
2000-02-02 |
2003-05-30 |
Univ Florida State Res Found |
Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
|
AU782028B2
(en)
|
2000-02-02 |
2005-06-30 |
Florida State University Research Foundation, Inc. |
C10 carbonate substituted taxanes as antitumor agents
|
US6649632B2
(en)
|
2000-02-02 |
2003-11-18 |
Fsu Research Foundation, Inc. |
C10 ester substituted taxanes
|
BR0104351A
(pt)
|
2000-02-02 |
2002-01-02 |
Univ Florida State Res Found |
Taxanos substituìdos com carbonato c7 como agentes antitumor
|
CA2368534A1
(en)
|
2000-02-02 |
2001-08-09 |
Florida State University Research Foundation, Inc. |
C7 heterosubstituted acetate taxanes as antitumor agents
|
JP2003522173A
(ja)
|
2000-02-02 |
2003-07-22 |
フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド |
抗腫瘍剤としてのc10カルバモイルオキシ置換タキサン
|
EP1165549B1
(de)
|
2000-02-02 |
2008-04-16 |
Florida State University Research Foundation, Inc. |
C7-carbamoyloxysubstituierte taxane als antitumormittel
|
US20020077290A1
(en)
|
2000-03-17 |
2002-06-20 |
Rama Bhatt |
Polyglutamic acid-camptothecin conjugates and methods of preparation
|
US6656966B2
(en)
|
2000-06-22 |
2003-12-02 |
Nitromed, Inc. |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
DE10032256C2
(de)
*
|
2000-07-03 |
2003-06-05 |
Infineon Technologies Ag |
Chip-ID-Register-Anordnung
|
EP1318794A2
(de)
*
|
2000-09-22 |
2003-06-18 |
Bristol-Myers Squibb Company |
Methode zur reduktion der toxizität von kombinationschemotherapien
|
CA2440935A1
(en)
*
|
2001-03-13 |
2002-09-19 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
HUP0600533A2
(en)
*
|
2001-11-30 |
2006-11-28 |
Bristol Myers Squibb Co |
Paclitaxel solvates
|
SI2264172T1
(sl)
|
2002-04-05 |
2017-12-29 |
Roche Innovation Center Copenhagen A/S |
Oligomerne spojine za modulacijo izražanja HIF-1alfa
|
EP3470084A1
(de)
*
|
2002-12-09 |
2019-04-17 |
Abraxis BioScience, LLC |
Zusammensetzungen enthaltend albuminnanopartikel und methoden zur freisetzung von wirkstoffen
|
ATE457716T1
(de)
|
2002-12-30 |
2010-03-15 |
Angiotech Int Ag |
Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
|
US7713738B2
(en)
*
|
2003-02-10 |
2010-05-11 |
Enzon Pharmaceuticals, Inc. |
Oligomeric compounds for the modulation of survivin expression
|
EP1498120A1
(de)
*
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Halbfeste Formulierung für die orale Verabreichung des Taxols
|
US7622453B2
(en)
|
2003-12-23 |
2009-11-24 |
Santaris Pharma A/S |
Oligomeric compounds for the modulation of Bcl-2
|
HN2005000054A
(es)
|
2004-02-13 |
2009-02-18 |
Florida State University Foundation Inc |
Taxanos sustituidos con esteres de ciclopentilo en c10
|
TW200540164A
(en)
|
2004-03-05 |
2005-12-16 |
Univ Florida State Res Found |
C7 lactyloxy-substituted taxanes
|
US7846940B2
(en)
*
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
NZ555644A
(en)
*
|
2004-11-09 |
2009-04-30 |
Santaris Pharma As |
Potent LNA oligonucleotides for the inhibition of HIF-1A expression
|
US9447138B2
(en)
|
2004-11-09 |
2016-09-20 |
Roche Innovation Center Copenhagen A/S |
Potent LNA oligonucleotides for the inhibition of HIF-1a expression
|
NZ555645A
(en)
*
|
2004-11-09 |
2009-08-28 |
Santaris Pharma As |
LNA oligonucleotides and the treatment of cancer
|
US7754850B2
(en)
|
2005-02-11 |
2010-07-13 |
University Of Southern California |
Chimeric disintegrin domain
|
US20070073385A1
(en)
*
|
2005-09-20 |
2007-03-29 |
Cook Incorporated |
Eluting, implantable medical device
|
WO2007130501A2
(en)
|
2006-05-01 |
2007-11-15 |
University Of Southern California |
Combination therapy for treatment of cancer
|
WO2008005284A2
(en)
|
2006-06-30 |
2008-01-10 |
Cook Incorporated |
Methods of manufacturing and modifying taxane coatings for implantable medical devices
|
US20080241215A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Robert Falotico |
Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
|
US8242166B2
(en)
|
2008-03-31 |
2012-08-14 |
Florida State University Research Foundation, Inc. |
C(10) ethyl ester and C(10) cyclopropyl ester substituted taxanes
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8273404B2
(en)
*
|
2008-05-19 |
2012-09-25 |
Cordis Corporation |
Extraction of solvents from drug containing polymer reservoirs
|
AU2009249067A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Neurogesx, Inc. |
Water-soluble acetaminophen analogs
|
AU2009249069A1
(en)
|
2008-05-20 |
2009-11-26 |
Neurogesx, Inc. |
Carbonate prodrugs and methods of using the same
|
US8642063B2
(en)
|
2008-08-22 |
2014-02-04 |
Cook Medical Technologies Llc |
Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
|
US9198968B2
(en)
|
2008-09-15 |
2015-12-01 |
The Spectranetics Corporation |
Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
|
US8802394B2
(en)
|
2008-11-13 |
2014-08-12 |
Radu O. Minea |
Method of expressing proteins with disulfide bridges with enhanced yields and activity
|
US20120302954A1
(en)
|
2011-05-25 |
2012-11-29 |
Zhao Jonathon Z |
Expandable devices coated with a paclitaxel composition
|
US20120303115A1
(en)
|
2011-05-25 |
2012-11-29 |
Dadino Ronald C |
Expandable devices coated with a rapamycin composition
|
US9956385B2
(en)
|
2012-06-28 |
2018-05-01 |
The Spectranetics Corporation |
Post-processing of a medical device to control morphology and mechanical properties
|
EP2875814B1
(de)
|
2012-07-19 |
2018-08-22 |
FUJIFILM Corporation |
Flüssige zusammensetzung mit wirkstoff auf taxanbasis, verfahren zur herstellung davon und flüssiges arzneimittel
|
CN103086924A
(zh)
*
|
2013-01-17 |
2013-05-08 |
暨明医药科技(苏州)有限公司 |
一种多西他赛及其中间体的合成方法
|
CN104650012A
(zh)
|
2013-11-22 |
2015-05-27 |
天士力控股集团有限公司 |
一种紫杉烷类化合物
|
CN108135917B
(zh)
|
2015-09-25 |
2021-07-09 |
Zy医疗 |
基于包含多糖-维生素缀合物的颗粒的药物制剂
|